North America Antibiotics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Antibiotics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Antibiotics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Antibiotics Market Regional Analysis

6.2 North America Antibiotics Market Revenue 2017-2027 (US$ Million)

6.3 North America Antibiotics Market Forecast Analysis

7. North America Antibiotics Market Analysis – by Drug Class

7.1 Sulfonamides

7.1.1 Overview
7.1.2 Sulfonamides: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Aminoglycosides

7.2.1 Overview
7.2.2 Aminoglycosides: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Carbapenem

7.3.1 Overview
7.3.2 Carbapenem: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Macrolides

7.4.1 Overview
7.4.2 Macrolides: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.5 Fluoroquinolones

7.5.1 Overview
7.5.2 Fluoroquinolones: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.6 Penicillin

7.6.1 Overview
7.6.2 Penicillin: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.7 Cephalosporin

7.7.1 Overview
7.7.2 Cephalosporin: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Antibiotics Market Analysis – by Action Mechanism

8.1 Mycolic Acid Inhibitors

8.1.1 Overview
8.1.2 Mycolic Acid Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 RNA Synthesis Inhibitors

8.2.1 Overview
8.2.2 RNA Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 DNA Synthesis Inhibitors

8.3.1 Overview
8.3.2 DNA Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Protein Synthesis Inhibitors

8.4.1 Overview
8.4.2 Protein Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.5 Cell Wall Synthesis Inhibitors

8.5.1 Overview
8.5.2 Cell Wall Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Antibiotics Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Antibiotics Market Breakdown, by Key Country, 2020 and 2027 (%)
9.2.1.1 North America Antibiotics Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.1.1 US: North America Antibiotics Market Breakdown, by Drug Class
9.2.1.1.2 US: North America Antibiotics Market Breakdown, by Action Mechanism

9.2.1.2 Canada: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.2.1 Canada: North America Antibiotics Market Breakdown, by Drug Class
9.2.1.2.2 Canada: North America Antibiotics Market Breakdown, by Action Mechanism

9.2.1.3 Mexico : North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.3.1 Mexico : North America Antibiotics Market Breakdown, by Drug Class
9.2.1.3.2 Mexico : North America Antibiotics Market Breakdown, by Action Mechanism

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Johnson & Johnson Services, Inc

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Bristol-Myers Squibb Company

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Eli Lilly and Company.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Abbott

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Pfizer Inc

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Antibiotics Market